Acorda Therapeutics Inc. (ACOR) spiked sharply to the downside late Friday morning after a Delaware Court invalidated 4 U.S. patents which pertain to AMPYRA. The company plans to appeal the decision.
from RTT - Before the Bell http://ift.tt/2o1NrYM
via IFTTT
No comments:
Post a Comment